Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05503953
PHASE3

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

View on ClinicalTrials.gov

Summary

A multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients with Essential Hypertension Inadequately Controlled with AGLS

Official title: A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

318

Start Date

2022-09-13

Completion Date

2025-06-10

Last Updated

2026-09-10

Healthy Volunteers

No

Interventions

DRUG

AGSAVI

Uptitation

DRUG

AGLS

Uptitration

Locations (1)

AhnGook

Seoul, South Korea